Hillstream BioPharma Inc. (HILS)
0.24
0.02 (7.00%)
At close: Sep 22, 2023, 7:59 PM
0.23
-2.62%
After-hours: Sep 22, 2023, 07:01 PM EDT
7.00% (1D)
| Bid | 0.23 |
| Market Cap | 4.17M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -1.6B |
| EPS (ttm) | -0.7 |
| PE Ratio (ttm) | -0.3385714285714286 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.25 |
| Volume | 313,195 |
| Avg. Volume (20D) | 684,778 |
| Open | 0.23 |
| Previous Close | 0.22 |
| Day's Range | 0.22 - 0.24 |
| 52-Week Range | 0.17 - 2.65 |
| Beta | 0.00 |
About HILS
Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) for the treatment resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors. It also develops HSB-888, a dual Quatramer loaded IMCD inducer coupled with its anthracycline analogue for solid tumors; HSB-510, a...
Industry Biotechnology
Sector Healthcare
IPO Date Jan 12, 2022
Employees 1
Stock Exchange NASDAQ
Ticker Symbol HILS
Website https://www.hillstreambio.com